Aniket Kawatkar to Adult
This is a "connection" page, showing publications Aniket Kawatkar has written about Adult.
Connection Strength
0.391
-
Utilization and Costs of Severe Uncontrolled Asthma in a Managed-Care Setting. J Allergy Clin Immunol Pract. 2016 Jan-Feb; 4(1):120-9.e3.
Score: 0.056
-
Acute colonic diverticulitis: diagnostic evidence, demographic and clinical features in three practice settings. J Gastrointestin Liver Dis. 2014 Dec; 23(4):379-86.
Score: 0.053
-
Development and validation of algorithms to identify acute diverticulitis. Pharmacoepidemiol Drug Saf. 2015 Jan; 24(1):27-37.
Score: 0.052
-
Impact of mental health comorbidities on health care utilization and expenditure in a large US managed care adult population with ADHD. Value Health. 2014 Sep; 17(6):661-8.
Score: 0.051
-
Direct medical expenditure associated with rheumatoid arthritis in a nationally representative sample from the medical expenditure panel survey. Arthritis Care Res (Hoboken). 2012 Nov; 64(11):1649-56.
Score: 0.045
-
Acute diverticulitis: demographic, clinical and laboratory features associated with computed tomography findings in 741 patients. Aliment Pharmacol Ther. 2012 Nov; 36(9):886-94.
Score: 0.045
-
Consumer knowledge and perceptions of formularies. Manag Care Interface. 2004 Jan; 17(1):21-6, 30.
Score: 0.025
-
Blood Eosinophil Count and Outcomes in Severe Uncontrolled Asthma: A Prospective Study. J Allergy Clin Immunol Pract. 2017 Jan - Feb; 5(1):144-153.e8.
Score: 0.015
-
Medication adherence and attrition to biologic treatment in rheumatoid arthritis patients. Clin Ther. 2015 Mar 01; 37(3):660-666.e8.
Score: 0.013
-
Prevalence and incidence of adult attention deficit/hyperactivity disorder in a large managed care population. Curr Med Res Opin. 2014 Jul; 30(7):1291-9.
Score: 0.013
-
Rapid assessment of cardiovascular risk among users of smoking cessation drugs within the US Food and Drug Administration's Mini-Sentinel program. JAMA Intern Med. 2013 May 13; 173(9):817-9.
Score: 0.012
-
Racial/ethnic differences in the use of biologic disease-modifying antirheumatic drugs among California Medicaid rheumatoid arthritis patients. Arthritis Care Res (Hoboken). 2013 Feb; 65(2):299-303.
Score: 0.012